Simon Jung

Showing 1-1 of 1 articles

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini G, Räber L, Meier B, Jüni P, Windecker S

January 18, 2013 | 10.4244/EIJV8I9A163

1

Latest news

State-of-the-Art on MINOCA; clopidogrel monotherapy; clinical presentation and bleeding risk after PCI; POT technique; LAAO; and more…

December 3, 2021

STATE OF THE ART

Myocardial infarction with non-obstructive coronary artery disease

December 3, 2021

EuroIntervention is now on Instagram

November 29, 2021

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

Is clopidogrel as the P2Y12 inhibitor a wise choice for long-term monotherapy in patients undergoing stenting?

December 3, 2021

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

Guidelines, consensus & position papers

consult the most recent published guidelines, consensus and position papers

November 29, 2021

Valvular disease